June 8, 2017August 24, 2022
Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows
News
Patients with unresectable or metastatic melanoma who were treated with Keytruda (pembrolizumab) in a pivotal clinical trial showed superior and sustained time ... Read more
June 6, 2017
New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test
News
Castle Biosciences presented three abstracts on the validity of using its 31-Gene Expression Profile (GEP) Test for melanoma prognosis at the ... Read more
June 1, 2017June 2, 2017
Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer
News
Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in ... Read more
May 30, 2017
Researchers Provide New Insights into Melanoma Immune Resistance
News
A new study presents detailed information into the processes used by cancer cells to evade and resist the immune response. Researchers studied ... Read more
May 25, 2017May 25, 2017
New Clinical Trial Underway for Treatment of Advanced Melanoma
News
A new clinical trial is underway assessing the addition of the first-in-class AXL kinase inhibitor, BGB324, to standard of care treatment for patients with ... Read more
May 23, 2017May 23, 2017
Skin Cancer Awareness Month Brings Sun Safety to Schools
News
Educating people of all ages, particularly children, about the dangers of sun exposure is urgent to preventing the increased prevalence ... Read more
May 18, 2017
First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma
News
The first patient has been enrolled in Targovax‘s pilot clinical trial for advanced or unresectable melanoma patients whose cancer progressed after treatment ... Read more
May 16, 2017
ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial
News
The combination of ImmunoPulse IL-12 and the anti-PD-1 therapy Keytruda (pembrolizumab) soon will be tested in a Phase 2 trial for treatment ... Read more
May 11, 2017
Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial
News
Adding the small molecule MEK inhibitor binimetinib to the BRAF inhibitor encorafenib was safe and significantly prolonged the time to disease progression ... Read more
May 9, 2017May 9, 2017
Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize
News
The Pershing Square Sohn Cancer Research Alliance has announced the six winners of the fourth edition of the annual Pershing ... Read more
May 4, 2017
Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma
News
Castle Biosciences’ DecisionDx-Melanoma test can be used to accurately predict cancer recurrence and metastasis in patients with head and neck melanoma, ... Read more
April 25, 2017
IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group
News
Prima Biomed, an Australian biotechnology company developing immunotherapies for cancer and autoimmune diseases, announced it has received approval for the ... Read more

January 20, 2015January 20, 2015

New Skin Formation Regulatory Mechanism Found

News

A new study entitled “Terminal epidermal differentiation is regulated by the interaction of Fra-2/AP-1 with Ezh2 and ERK1/2” reveals a new mechanism by which keratinocyte differentiation is regulated, the key ... Read more

January 19, 2015January 19, 2015

Study Reveals Mechanisms Behind Melanoma Combination Therapy Resistance

News

Researchers from the UCLA Jonsson Comprehensive Cancer Center have published their latest results in the journal Cancer Cell, whereby they reveal how melanoma cells can become resistant to BRAF and ... Read more

January 16, 2015January 16, 2015

Children of Melanoma Survivors Not Adequately Protected From Sun’s Harmful Exposure

News

According to a study from UCLA’s Jonsson Comprehensive Cancer Center researchers, children whose progenitors survived melanoma are not adequately using sun protection. This is especially alarming, as these children have ... Read more

January 15, 2015January 15, 2015

Metastatic Melanoma in Mice Treated with ALS Therapeutic and Radiation

Melanoma, News

Melanoma that has metastasized to the brain may be more effectively treated using radiation therapy in combination with the drug riluzole than with radiation alone. Researchers at Rutgers Cancer Institute ... Read more

January 14, 2015January 14, 2015

Novel Mechanism Behind Melanoma Drug Resistance Unveiled

News

Recent research has unveiled the mechanisms responsible for targeted therapy resistance in melanoma patients. This type of therapy has a lower toxicity rate and can improve results for different types ... Read more

January 13, 2015January 13, 2015

Wound-Induced Skin Cancer Triggered By Bacteria

News

In a new study entitled “Innate sensing of microbial products promotes wound-induced skin cancer” a team of researchers at the King’s College London discovered that immune cells’ recognition of bacteria ... Read more

January 12, 2015January 12, 2015

Genetic Test for Melanoma Metastasis from Castle Biosciences Validated in Recent Study

Melanoma, News

A recent study published in Clinical Cancer Research, “Development of a Prognostic Genetic Signature to Predict the Metastatic Risk Associated with Cutaneous Melanoma,” used Texas-based Castle Bioscience’s DecisionDx-Melanoma test for cutaneous ... Read more

January 9, 2015January 9, 2015

New Mouse Cell Line To Study BRAF Melanoma

News

A team of Dartmouth scientists has developed a cell line that can be used as a research tool for investigators using mice models of melanoma. In the study, published in ... Read more

January 8, 2015January 8, 2015

Melanoma Pigmentation Linked to Mitochondrial ROS Levels

Melanoma, News

A new study from The Medical School of Newcastle University is assigning guilt by association to mitochondrial function and melanoma. Melanoma skin cancer cells that display high levels of pigmentation ... Read more

January 7, 2015January 7, 2015

Genentech Submits New Drug Application to FDA for Cobimetinib And Zelboraf Combination For Advanced Melanoma Treatment

News

Genentech, a member of the Roche Group, submitted a New Drug Application (NDA) to the U.S Food and Drug Administration (FDA) for the use of cobimetinib in combination with Zelboraf ... Read more

January 6, 2015January 6, 2015

Indoor Tanning Decreases Among U.S. High School Students But Still Concerning

News

According to recent research from the U.S. Centers for Disease Control and Prevention, the trend in indoor tanning among high school students is on the decline. However, white females remain the demographic with the highest ... Read more

January 5, 2015January 5, 2015

Researchers Identify Gene Mutations Involved In Majority Of Melanomas

News

Recent research from the University of Louisville’s James Graham Brown Cancer Center has identified mutations responsible for DNA structure alterations that turn off genes located at four different sites of ... Read more

Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

Researchers Provide New Insights into Melanoma Immune Resistance

New Clinical Trial Underway for Treatment of Advanced Melanoma

Skin Cancer Awareness Month Brings Sun Safety to Schools

First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma

ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial

Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial

Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize

Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma

IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group